MTVA vs KOPN

Analysts rate Kopin Corporation (KOPN) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison.

The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Kopin Corporation (KOPN) delivered a total return of -37.

1%, compared to -47. 4% for MetaVia Inc. (MTVA). Over 10 years, the gap is even starker: KOPN returned +183. 5% versus MTVA's -47. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), MetaVia Inc.

(MTVA) is the lower-risk stock at 0. 67β versus Kopin Corporation's 3. 50β — meaning KOPN is approximately 419% more volatile than MTVA relative to the S&P 500. On balance sheet safety, MetaVia Inc. (MTVA) carries a lower debt/equity ratio of 2% versus 9% for Kopin Corporation — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: MetaVia Inc.

grew EPS -44. 7% year-over-year, compared to -83. 3% for Kopin Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

MetaVia Inc.

(MTVA) is the more profitable company, earning 0. 0% net margin versus -87. 2% for Kopin Corporation — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MTVA leads at 0. 0% versus -85. 6% for KOPN. At the gross margin level — before operating expenses — KOPN leads at 20. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, MetaVia Inc.

(MTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67)). Kopin Corporation (KOPN) carries a higher beta of 3. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MTVA: -47. 4%, KOPN: +183. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MTVA (Healthcare) and KOPN (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MTVA is a small-cap quality compounder stock; KOPN is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.